A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 135 participants.
Also called NCT02748057
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 135 participants
- Sponsor
- Registry
-
NCT02748057
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Not reported
- Registry status
- Completed
Technical summary
Registry record NCT02748057. Randomized; no masking; primary purpose treatment. Start 2016-05-18 (actual); primary completion 2017-12-11 (actual). Results posted on 2018-12-04.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Clinical Trial to Assess the Long Term Safety and Tolerability of MK-0653H in Japanese Participants With Hypercholesterolemia (MK-0653H-833)
- Condition
- Hypercholesterolemia
- Condition
- Familial Hypercholesterolemia
- Intervention (Drug)
- Ezetimibe
- Intervention (Drug)
- Rosuvastatin
- Lead sponsor
- Organon and Co
Record details
- Record id
cardio:ct-nct02748057- Content hash
71227b1b1889094eb8aa157da2d60f2057ef21570a5a732737ebb191ddfda07b